HCCI's 2019 HCCUR was featured in a Center for American Progress report on employer- and worker-led efforts to lower health insurance costs. From the article: "Rising health care prices—not utilization—is the primary driver of the rising cost of commercial insurance." Employer- and Worker-Led Efforts To Lower Health Insurance Costs - Center for American Progress Individual employers have limited a...
The International Federation of Health Plans (iFHP), an executive network of the global health insurance industry based in London, in partnership with the Health Care Cost Institute (HCCI) in the United States, and iFHP member companies in multiple countries, today published the latest International Health Cost Comparison Report. The report compares the median prices paid by a sample of private he...
Over 10% of the U.S. population— more than 34 million individuals— lives with diabetes, with 1.5 million new cases diagnosed each year. As people with diabetes manage this chronic condition, they often pay substantial amounts out of their own pockets on medical care and prescription medications. Using HCCI's unique health care claims dataset, this brief illustrates the impact of diabetes on the us...
HCCI's research on insulin prices was featured in a Healthcare Dive brief on California's plan to manufacture its own insulin. From the article: "The Health Care Cost Institute found nearly 9% of patients with private insurance paid an average of $403 per month for their insulin in 2019." California to manufacture its own insulin, Newsom says | Healthcare Dive Healthcare https://www.healthca...
We'll admit it: we have missed in-person conferences! In June, HCCI staff attended AcademyHealth's Annual Research Meeting (ARM) and ASHEcon. In addition to connecting with other health services researchers, staff presented original research using HCCI's commercial claims dataset. Here's a sampling of HCCI staff presentations: ASHEcon: Real World Consequences o...
